Trial intelligence / Profile preview

Allergen immunotherapy plus vitamin D3 for grass pollen allergic rhinitis

NL-OMON28331Active, not recruiting

Sponsor
Prof. dr. W.J. Fokkens, ENT surgeon Department of Otorhinolaryngology, Room A2-234, Academic Medical Center, Amsterdam [email protected] phone: +31 20 5663789 fax: +31 20 5669573
Start
Dec 2005
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Countries
1
01

Overview

Trial of PURETHAL Grasses and calcitriol in allergic rhinitis (AR) (4 arms), sponsored by Prof. dr. W.J. Fokkens, ENT surgeon Department of Otorhinolaryngology, Room A2-234, Academic Medical Center, Amsterdam [email protected] phone: +31 20 5663789 fax: +31 20 5669573. Primary endpoint: Early reduction of allergen-induced inflammation at 9 weeks. Started Dec 2005; status: active, not recruiting.

02

Drugs

PURETHAL Grassescalcitriol
03

Conditions

allergic rhinitis (AR)

Beyond the preview

Go deeper on NL-OMON28331.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON28331.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call